Cargando…

A Critical Dialogue: Communicating with Type 2 Diabetes Patients about Cardiovascular Risk

Patients with type 2 diabetes mellitus (DM) are at increased risk for cardiovascular disease (CVD), and many patients are inadequately treated for risk factors such as hyperglycemia, hyperlipidemia, hypertension, and smoking. Providing individualized risk information in a clear and engaging manner m...

Descripción completa

Detalles Bibliográficos
Autores principales: Roach, Paris, Marrero, David
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1993965/
https://www.ncbi.nlm.nih.gov/pubmed/17315602
_version_ 1782135457148043264
author Roach, Paris
Marrero, David
author_facet Roach, Paris
Marrero, David
author_sort Roach, Paris
collection PubMed
description Patients with type 2 diabetes mellitus (DM) are at increased risk for cardiovascular disease (CVD), and many patients are inadequately treated for risk factors such as hyperglycemia, hyperlipidemia, hypertension, and smoking. Providing individualized risk information in a clear and engaging manner may serve to encourage both patients and their physicians to intensify risk-reducing behaviors and therapies. This review outlines simple and effective methods for making CVD risk infomation understandable to persons of all levels of literacy and mathematical ability. To allow the patient to understand what might happen and how, personal risk factors should be clearly communicated and the potential consequences of a CVD event should be presented in a graphic but factual manner. Risk calculation software can provide CVD risk estimates, and the resulting information can be made understandable by assigning risk severity (eg, “high”) by comparing clinical parameters with accepted treatment targets and by comparing the individual's risk with that of the “average” person. Patients must also be informed about how they might reduce their CVD risk and be supported in these efforts. Thoughtful risk communication using these techniques can improve access to health information for individuals of low literacy, especially when interactive computer technology is employed. Research is needed to find the best methods for communicating risk in daily clinical practice.
format Text
id pubmed-1993965
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-19939652008-03-06 A Critical Dialogue: Communicating with Type 2 Diabetes Patients about Cardiovascular Risk Roach, Paris Marrero, David Vasc Health Risk Manag Review Patients with type 2 diabetes mellitus (DM) are at increased risk for cardiovascular disease (CVD), and many patients are inadequately treated for risk factors such as hyperglycemia, hyperlipidemia, hypertension, and smoking. Providing individualized risk information in a clear and engaging manner may serve to encourage both patients and their physicians to intensify risk-reducing behaviors and therapies. This review outlines simple and effective methods for making CVD risk infomation understandable to persons of all levels of literacy and mathematical ability. To allow the patient to understand what might happen and how, personal risk factors should be clearly communicated and the potential consequences of a CVD event should be presented in a graphic but factual manner. Risk calculation software can provide CVD risk estimates, and the resulting information can be made understandable by assigning risk severity (eg, “high”) by comparing clinical parameters with accepted treatment targets and by comparing the individual's risk with that of the “average” person. Patients must also be informed about how they might reduce their CVD risk and be supported in these efforts. Thoughtful risk communication using these techniques can improve access to health information for individuals of low literacy, especially when interactive computer technology is employed. Research is needed to find the best methods for communicating risk in daily clinical practice. Dove Medical Press 2005-12 2005-12 /pmc/articles/PMC1993965/ /pubmed/17315602 Text en © 2005 Dove Medical Press Limited. All rights reserved
spellingShingle Review
Roach, Paris
Marrero, David
A Critical Dialogue: Communicating with Type 2 Diabetes Patients about Cardiovascular Risk
title A Critical Dialogue: Communicating with Type 2 Diabetes Patients about Cardiovascular Risk
title_full A Critical Dialogue: Communicating with Type 2 Diabetes Patients about Cardiovascular Risk
title_fullStr A Critical Dialogue: Communicating with Type 2 Diabetes Patients about Cardiovascular Risk
title_full_unstemmed A Critical Dialogue: Communicating with Type 2 Diabetes Patients about Cardiovascular Risk
title_short A Critical Dialogue: Communicating with Type 2 Diabetes Patients about Cardiovascular Risk
title_sort critical dialogue: communicating with type 2 diabetes patients about cardiovascular risk
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1993965/
https://www.ncbi.nlm.nih.gov/pubmed/17315602
work_keys_str_mv AT roachparis acriticaldialoguecommunicatingwithtype2diabetespatientsaboutcardiovascularrisk
AT marrerodavid acriticaldialoguecommunicatingwithtype2diabetespatientsaboutcardiovascularrisk
AT roachparis criticaldialoguecommunicatingwithtype2diabetespatientsaboutcardiovascularrisk
AT marrerodavid criticaldialoguecommunicatingwithtype2diabetespatientsaboutcardiovascularrisk